BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24444361)

  • 1. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
    Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
    Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
    Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
    PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
    Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
    Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S; Udagawa O
    Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
    Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
    PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
    PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
    J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
    Becker KA; Florin L; Sapp C; Maul GG; Sapp M
    J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
    Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
    Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
    Day PM; Baker CC; Lowy DR; Schiller JT
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14252-7. PubMed ID: 15383670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation promotes PML degradation during encephalomyocarditis virus infection.
    El McHichi B; Regad T; Maroui MA; Rodriguez MS; Aminev A; Gerbaud S; Escriou N; Dianoux L; Chelbi-Alix MK
    J Virol; 2010 Nov; 84(22):11634-45. PubMed ID: 20826694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
    Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2.
    Marcos-Villar L; Campagna M; Lopitz-Otsoa F; Gallego P; González-Santamaría J; González D; Rodriguez MS; Rivas C
    J Gen Virol; 2011 Jan; 92(Pt 1):188-94. PubMed ID: 20881090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.